PTGX Historical Earnings image   This PTGX historical earnings page last updated 11/11/2024
PTGX Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202411/7/20240.00B
Q2 20248/6/20240.00B
Q1 20245/7/20240.25B
Q4 20232/27/20240.06B
Q3 202311/2/2023NA
Q2 20238/3/2023NA
Q1 20235/4/2023NA
Q4 20223/15/2023NA
Q3 202211/8/2022NA
Q2 20228/4/20220.00B
Q1 20225/4/20220.03B
Q4 20212/28/20220.01B
Q3 202111/3/20210.01B
Q2 20218/4/20210.00B
Q1 20215/4/20210.01B
Q4 20203/10/20210.01B
Q3 202011/4/20200.01B
Q2 20208/6/20200.01B
Q1 20205/7/20200.00B
Q4 20193/10/20200.00B
Q3 201911/6/20190.00B
Q2 20198/7/2019-0.01B
Q1 20195/8/20190.00B
Q4 20183/12/20192.35M
Q3 201811/6/20186.12M
Q2 20188/7/201811.67M
Q1 20185/9/201810.78M
Q4 20173/7/201811.28M
Q3 201711/6/20178.78M
Q2 20178/8/2017NA
Q1 20175/10/2017NA
Q4 20163/7/2017NA
Q3 201611/14/2016NA
PTGX Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202411/7/2024-0.540
Q2 20248/6/2024-0.500
Q1 20245/7/20243.260
Q4 20232/27/20240.440
Q3 202311/2/2023-0.580
Q2 20238/3/2023-0.680
Q1 20235/4/2023-0.670
Q4 20223/15/2023-0.690
Q3 202211/8/2022-0.640
Q2 20228/4/2022-0.840
Q1 20225/4/2022-0.430
Q4 20212/28/2022-0.770
Q3 202111/3/2021-0.700
Q2 20218/4/2021-0.690
Q1 20215/4/2021-0.540
Q4 20203/10/2021-0.480
Q3 202011/4/2020-0.210
Q2 20208/6/2020-0.590
Q1 20205/7/2020-0.720
Q4 20193/10/2020-0.630
Q3 201911/6/2019-0.610
Q2 20198/7/2019-1.180
Q1 20195/8/2019-0.580
Q4 20183/12/2019-0.57
Q3 201811/6/2018-0.38
Q2 20188/7/2018-0.41
Q1 20185/9/2018-0.36
Q4 20173/7/2018-0.15
Q3 201711/6/2017-0.29
Q2 20178/8/2017-0.89
Q1 20175/10/2017-0.84
Q4 20163/7/2017-0.67
Q3 201611/14/2016-0.87
Quotes delayed 20 minutes

Email EnvelopeFree PTGX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Protagonist Therapeutics (PTGX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

PTIX Historical Earnings
PTPI Historical Earnings
PULM Historical Earnings
PYXS Historical Earnings
QDEL Historical Earnings
QLGN Historical Earnings
QNCX Historical Earnings
QTRX Historical Earnings
QTTB Historical Earnings
RAIN Historical Earnings
What was the record high PTGX historical earnings result?
In terms of earnings or revenue, what is the best PTGX historical earnings result that Protagonist Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest PTGX historical earnings result was set in Q1 2024, when Protagonist Therapeutics posted results of 3.260/share. The most successful revenue quarter within our data set was Q1 2024 when Protagonist Therapeutics reported revenue of 0.25B.

What was the lowest Protagonist Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest PTGX has reported, and when?

✔️Accepted answer: Within our data set, the lowest PTGX historical earnings result was set in Q2 2019, when Protagonist Therapeutics posted results of -1.180/share. The smallest revenue quarter within our data set was Q2 2019 when Protagonist Therapeutics reported revenue of -0.01B.

On this page we presented the PTGX historical earnings date information for Protagonist Therapeutics. Reviewing that PTGX Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2024, when PTGX posted gaap of 3.260/share. Meanwhile the lowest PTGX historical earnings result was in Q2 2019, when PTGX posted gaap of -1.180/share. Moving to Protagonist Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q1 2024 when PTGX reported 0.25B in revenue, while the smallest revenue quarter was Q2 2019 when PTGX reported -0.01B in revenue.

For self directed investors doing their due diligence on PTGX or any other given stock, their research can benefit from looking into all of the Protagonist Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Protagonist Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for PTGX. Thanks for visiting, and the next time you need to research PTGX historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: BCC Next Earnings Date, Funds Holding IXUS, LUMN market cap history.

 

PTGX Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.